Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 3,387.67 | 1,626.98 | 2,889.21¢ | 16.4 | 2.5 | +6% | n/a | 0.0% |
| 31-Dec-27 | 3,750.15 | 1,765.69 | 3,120.78¢ | 15.2 | 1.9 | +8% | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
| Contracting | 06-Dec-2007 | Washington Post |
| United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
| Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
| Currency | US Dollars |
| Share Price | $ 473.66 |
| Change Today | $ -2.47 |
| % Change | -0.52 % |
| 52 Week High | $517.13 |
| 52 Week Low | $274.70 |
| Volume | 258,650 |
| Shares Issued | 43.56m |
| Market Cap | $20,634m |
| RiskGrade | 132 |
| Strong Buy | 6 |
| Buy | 3 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 15 |

| Time | Volume / Share Price |
| 15:59 | 72 @ $473.13 |
| 15:59 | 58 @ $473.49 |
| 15:59 | 160 @ $473.69 |
| 15:59 | 40 @ $473.61 |
| 15:59 | 40 @ $473.37 |
You are here: research